Baird Financial Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
29,059
+17,186
| +145% | +$91.3K | ﹤0.01% | 1722 |
|
|
2025
Q1 | $105K | Buy |
+11,873
| New | +$105K | ﹤0.01% | 1717 |
|
|
2022
Q3 | – | Sell |
-15,662
| Closed | -$285K | – | 1791 |
|
|
2022
Q2 | $285K | Buy |
15,662
+394
| +3% | +$7.17K | ﹤0.01% | 1575 |
|
|
2022
Q1 | $384K | Buy |
15,268
+957
| +7% | +$24.1K | ﹤0.01% | 1522 |
|
|
2021
Q4 | $395K | Sell |
14,311
-30
| -0.2% | -$828 | ﹤0.01% | 1570 |
|
|
2021
Q3 | $463K | Buy |
+14,341
| New | +$463K | ﹤0.01% | 1494 |
|
|
2016
Q4 | – | Sell |
-26,936
| Closed | -$554K | – | 1233 |
|
|
2016
Q3 | $554K | Sell |
26,936
-28,757
| -52% | -$591K | 0.01% | 910 |
|
|
2016
Q2 | $1.7M | Sell |
55,693
-33,305
| -37% | -$1.02M | 0.02% | 594 |
|
|
2016
Q1 | $3.33M | Buy |
88,998
+1,405
| +2% | +$52.6K | 0.03% | 437 |
|
|
2015
Q4 | $3.78M | Sell |
87,593
-19
| -0% | -$820 | 0.04% | 398 |
|
|
2015
Q3 | $3.28M | Sell |
87,612
-2,635
| -3% | -$98.8K | 0.03% | 411 |
|
|
2015
Q2 | $3.07M | Buy |
+90,247
| New | +$3.07M | 0.03% | 448 |
|